HEMITARTARATO DE RIVASTIGMINA 3 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1006302780224 -
GGREM
513423100034406 -
Barcode
7897406120738
What the source publishes
- Holder
- INSTITUTO BIOCHIMICO INDÚSTRIA FARMACÊUTICA LTDA
- Active ingredients
- HEMITARTARATO DE RIVASTIGMINA
- Package
- 3 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30
- Supply regime
- Tarja Vermelha sob restrição
- Product type
- Genérico
- Therapeutic class
- N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE
- Prescription
- Prescription or restricted
Names this record is found by
- HEMITARTARATO DE RIVASTIGMINA 3 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30
- HEMITARTARATO DE RIVASTIGMINA
Complete source data
{
"name": "HEMITARTARATO DE RIVASTIGMINA 3 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30",
"holder": "INSTITUTO BIOCHIMICO INDÚSTRIA FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7897406120738"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "513423100034406",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.258.401/0001-03",
"priceRegime": "Regulado",
"productName": "HEMITARTARATO DE RIVASTIGMINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "3 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "155.82",
"icms-12": "177.07",
"icms-17": "187.73",
"icms-18": "190.02",
"icms-19": "192.37",
"icms-20": "194.78",
"icms-21": "197.24",
"icms-22": "199.77",
"icms-23": "202.36",
"icms-17.5": "188.87",
"icms-19.5": "193.57",
"icms-20.5": "196.00",
"icms-22.5": "201.06",
"icms-12-alc": "174.94",
"icms-17-alc": "185.48",
"icms-18-alc": "187.74",
"icms-19-alc": "190.06",
"icms-20-alc": "192.44",
"icms-21-alc": "194.87",
"icms-22-alc": "197.37",
"icms-23-alc": "199.94",
"withoutTaxes": "153.95",
"icms-17.5-alc": "186.61",
"icms-19.5-alc": "191.24",
"icms-20.5-alc": "193.65",
"icms-22.5-alc": "198.65"
},
"pisCofinsList": "Positiva",
"substanceText": "HEMITARTARATO DE RIVASTIGMINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "214.78",
"icms-12": "244.07",
"icms-17": "258.77",
"icms-18": "261.92",
"icms-19": "265.16",
"icms-20": "268.48",
"icms-21": "271.87",
"icms-22": "275.36",
"icms-23": "278.93",
"icms-17.5": "260.34",
"icms-19.5": "266.82",
"icms-20.5": "270.17",
"icms-22.5": "277.14",
"icms-12-alc": "241.84",
"icms-17-alc": "256.42",
"icms-18-alc": "259.54",
"icms-19-alc": "262.75",
"icms-20-alc": "266.04",
"icms-21-alc": "269.40",
"icms-22-alc": "272.85",
"icms-23-alc": "276.41",
"withoutTaxes": "212.83",
"icms-17.5-alc": "257.98",
"icms-19.5-alc": "264.38",
"icms-20.5-alc": "267.71",
"icms-22.5-alc": "274.62"
},
"invalidBarcodes": [],
"activeSubstances": [
"HEMITARTARATO DE RIVASTIGMINA"
],
"therapeuticClass": "N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006302780224",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N7D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:513423100034406"